000 01404 a2200325 4500
005 20250515095043.0
264 0 _c20080225
008 200802s 0 0 eng d
022 _a1557-1904
024 7 _a10.1007/s11481-006-9050-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGendelman, Howard E
245 0 0 _aBiomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disorders.
_h[electronic resource]
260 _bJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
_cMar 2007
300 _a8-13 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAIDS Dementia Complex
_xdiagnosis
650 0 4 _aAcquired Immunodeficiency Syndrome
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aBiomarkers
_xanalysis
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aDrug Design
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
773 0 _tJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
_gvol. 2
_gno. 1
_gp. 8-13
856 4 0 _uhttps://doi.org/10.1007/s11481-006-9050-2
_zAvailable from publisher's website
999 _c17555936
_d17555936